HYPERTENSION IN POSTMENOPAUSAL WOMEN: RATIONALE FOR THE USE OF CALCIUM CHANNEL BLOCKERS IN ANTIHYPERTENSIVE THERAPY

The choice of antihypertensive drugs for the treatment of hypertensive patients is discussed. Modern recommendations on the use of antihyperten-sive drugs in various clinical situations (lesion of target organs and the presence of concomitant conditions) are presented. Characteristics of patients wi...

Full description

Bibliographic Details
Main Authors: O. A. Kislyak, A. V. Starodubova, A. A. Kopelev
Format: Article
Language:English
Published: Столичная издательская компания 2017-07-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
Online Access:https://www.rpcardio.online/jour/article/view/1491
_version_ 1797232223000199168
author O. A. Kislyak
A. V. Starodubova
A. A. Kopelev
author_facet O. A. Kislyak
A. V. Starodubova
A. A. Kopelev
author_sort O. A. Kislyak
collection DOAJ
description The choice of antihypertensive drugs for the treatment of hypertensive patients is discussed. Modern recommendations on the use of antihyperten-sive drugs in various clinical situations (lesion of target organs and the presence of concomitant conditions) are presented. Characteristics of patients with hypertension and obesity in the postmenopausal period are presented with using authors own data. The expediency of using the last generation of calcium channel blockers in this clinical situation with an emphasis on lercanidipine is justified.
first_indexed 2024-03-08T14:02:58Z
format Article
id doaj.art-458a92b4617d479998cc81cb14a67121
institution Directory Open Access Journal
issn 1819-6446
2225-3653
language English
last_indexed 2024-04-24T15:56:51Z
publishDate 2017-07-01
publisher Столичная издательская компания
record_format Article
series Рациональная фармакотерапия в кардиологии
spelling doaj.art-458a92b4617d479998cc81cb14a671212024-04-01T07:43:35ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532017-07-0113339139710.20996/1819-6446-2017-13-3-391-3971354HYPERTENSION IN POSTMENOPAUSAL WOMEN: RATIONALE FOR THE USE OF CALCIUM CHANNEL BLOCKERS IN ANTIHYPERTENSIVE THERAPYO. A. Kislyak0A. V. Starodubova1A. A. Kopelev2Pirogov Russian National Research Medical UniversityPirogov Russian National Research Medical University; Federal Research Center for Nutrition, Biotechnology and Food SafetyPirogov Russian National Research Medical UniversityThe choice of antihypertensive drugs for the treatment of hypertensive patients is discussed. Modern recommendations on the use of antihyperten-sive drugs in various clinical situations (lesion of target organs and the presence of concomitant conditions) are presented. Characteristics of patients with hypertension and obesity in the postmenopausal period are presented with using authors own data. The expediency of using the last generation of calcium channel blockers in this clinical situation with an emphasis on lercanidipine is justified.https://www.rpcardio.online/jour/article/view/1491hypertensionobesitypostmenopausecalcium channel blockerslercanidipine
spellingShingle O. A. Kislyak
A. V. Starodubova
A. A. Kopelev
HYPERTENSION IN POSTMENOPAUSAL WOMEN: RATIONALE FOR THE USE OF CALCIUM CHANNEL BLOCKERS IN ANTIHYPERTENSIVE THERAPY
Рациональная фармакотерапия в кардиологии
hypertension
obesity
postmenopause
calcium channel blockers
lercanidipine
title HYPERTENSION IN POSTMENOPAUSAL WOMEN: RATIONALE FOR THE USE OF CALCIUM CHANNEL BLOCKERS IN ANTIHYPERTENSIVE THERAPY
title_full HYPERTENSION IN POSTMENOPAUSAL WOMEN: RATIONALE FOR THE USE OF CALCIUM CHANNEL BLOCKERS IN ANTIHYPERTENSIVE THERAPY
title_fullStr HYPERTENSION IN POSTMENOPAUSAL WOMEN: RATIONALE FOR THE USE OF CALCIUM CHANNEL BLOCKERS IN ANTIHYPERTENSIVE THERAPY
title_full_unstemmed HYPERTENSION IN POSTMENOPAUSAL WOMEN: RATIONALE FOR THE USE OF CALCIUM CHANNEL BLOCKERS IN ANTIHYPERTENSIVE THERAPY
title_short HYPERTENSION IN POSTMENOPAUSAL WOMEN: RATIONALE FOR THE USE OF CALCIUM CHANNEL BLOCKERS IN ANTIHYPERTENSIVE THERAPY
title_sort hypertension in postmenopausal women rationale for the use of calcium channel blockers in antihypertensive therapy
topic hypertension
obesity
postmenopause
calcium channel blockers
lercanidipine
url https://www.rpcardio.online/jour/article/view/1491
work_keys_str_mv AT oakislyak hypertensioninpostmenopausalwomenrationalefortheuseofcalciumchannelblockersinantihypertensivetherapy
AT avstarodubova hypertensioninpostmenopausalwomenrationalefortheuseofcalciumchannelblockersinantihypertensivetherapy
AT aakopelev hypertensioninpostmenopausalwomenrationalefortheuseofcalciumchannelblockersinantihypertensivetherapy